Menu Search
Equities

Central Proteina Prima Tbk PT

4PT:STU

Central Proteina Prima Tbk PT

Actions
  • Price (EUR)0.0005
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-92.31%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in IDRIncome statement in IDRView more

Year on year Central Proteina Prima Tbk PT grew net income 7.44% from 373.67bn to 401.47bn primarily through revenue growth (8.24tn to 9.03tn). For while the costs associated with cost of goods, selling, general and administrative and debt all increased as a percentage of sales, the 9.52% growth in revenues contributed enough to still see net income improve.
Gross margin19.16%
Net profit margin4.62%
Operating margin8.00%
Return on assets6.04%
Return on equity11.65%
Return on investment8.85%
More ▼

Cash flow in IDRView more

In 2023, Central Proteina Prima Tbk PT did not generate a significant amount of cash. However, the company earned 323.49bn from its operations for a Cash Flow Margin of 3.58%. In addition the company used 115.93bn on investing activities and also paid 209.45bn in financing cash flows.
Cash flow per share9.56
Price/Cash flow per share5.20
Book value per share63.04
Tangible book value per share63.04
More ▼

Balance sheet in IDRView more

Central Proteina Prima Tbk PT has a Debt to Total Capital ratio of 34.55%, a higher figure than the previous year's 25.31%.
Current ratio1.09
Quick ratio0.4647
Total debt/total equity0.5283
Total debt/total capital0.3455
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.